Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

The cost of Ebola

Jun 26, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

Botox is a multi-billion dollar, potentially deadly monopoly

by Kai Ryssdal, Emily Henderson, and Sean McHenry Oct 31, 2017
The product comes from a substance so lethal that it could be used as a potential agent of bioterrorism.
Andreas Rentz/Getty Images
The Price of Profits

Pharma: an industry shaped by shareholder value

by Dan Bobkoff Jun 15, 2016
Big drug companies today have remade their business models.
Big Pharma has remade their business models over time to maximize shareholder value. 
Joe Raedle/Getty Images

The only way to stop inversions might be tax reform

by Dan Gorenstein Apr 6, 2016
The Pfizer-Allergan merger is out, but what about inversions across the board?
Pfizer was set to merge with Allergan, but after new inversion rules announced by the Treasury Department, the phama giants decided against merging. 
Spencer Platt/Getty Images

Pfizer abandons $160B Allergan deal

by Marketplace Staff Apr 6, 2016
A change in U.S. tax laws has put a halt to the merger.
The outside of Pfizer's headquarters.
Mario Tama/Getty Images

Pfizer's tax-driven Allergan merger

by Tracey Samuelson Nov 23, 2015
Regulators want to cut down on these deals, but this one is full-speed ahead.

Pfizer and Allergan agree to $160 billion "inversion"

by Kimberly Adams Nov 23, 2015
The deal would create the largest pharmaceutical company in the world.

Activist investors help shareholders, right?

by David Brancaccio Apr 22, 2014
A new study says activist investors generated 48 percent average gain for companies they targeted.

Invest in Marketplace today

Ask not what Marketplace can do for you, but what you can do for Marketplace.

Botox might help migraines

by Lori Stassi Sep 12, 2008
Botox eases wrinkles, but can it also ease migraine headaches? Allergan says it can. The company that produces Botox reports that two large tests...

We’re counting on you today!

Marketplace helps you stay financially responsible all year, now we need YOUR help to keep our budget on track.
Donate NOW to help us hit our target of 2,500 Marketplace Investors by June 30!